physiotherapy  Equipment Recommendation FormBiomation, Canada

NeuroMove NM900™ Superior Outcomes

How much progress will your stroke patients make in the course of a 3-month rehabilitation program

Therapy                                                             Funtional Improvement

Proprioceptive Neuromuscular Facilitation...................................................18%

Bias/Balance with E-stim...........................................................................25%

***EMG triggered Neuromuscular Stimulation (ETMS)....43%***

Data is from a study by Dr. George Kraft, Department of Rehabilitation Medicine, University of Washington, Seattle, on groups of patients. Each patient had reached a plateau prior to therapy.


NeuroMove Users in Canada

The NeruoMove NM900 is used at the leading stroke treatment and recovery centers in Canada to provide ETMS therapy for accelerating progress, increasing patient motivation and improving outcomes.